免疫原性细胞死亡
免疫系统
程序性细胞死亡
钙网蛋白
体内
抗原
细胞内
分泌物
接种疫苗
癌症研究
免疫学
生物
细胞生物学
细胞凋亡
免疫疗法
内质网
生物化学
生物技术
作者
Kazuki Tatsuno,Patrick Han,Richard L. Edelson,Douglas Hanlon
标识
DOI:10.1007/978-1-0716-1162-3_15
摘要
Immunogenic cell death (ICD) is a form of regulated cell death that is capable of eliciting an immune response. In cancer, tumor cells undergoing ICD are known to emit damage associated molecular patterns (DAMPs) that are capable of recruiting and activating antigen presenting cells (APCs), which ultimately lead to the activation of an antitumor immune response. Surface translocation of intracellular chaperones such as calreticulin, release of TLR agonists such as high mobility box 1, and the secretion of type I IFN are some of the hallmark features seen in tumors succumbing to ICD. While detection of these molecules is suggestive of ICD induction, which alone does not certify that the treatment is an ICD inducer, an in vivo vaccination assay using injured tumor cells remains to be the gold standard method to functionally verify ICD. This chapter will discuss the necessary steps required to conduct an in vivo vaccination assay, focusing on the preparation of vaccine using treated tumor cells, and how these cells are then utilized in the animal model.
科研通智能强力驱动
Strongly Powered by AbleSci AI